Imhm321 Week 2 Lecture - Review of Genetics - Immunology in Blood Banking
Imhm321 Week 2 Lecture - Review of Genetics - Immunology in Blood Banking
Imhm321 Week 2 Lecture - Review of Genetics - Immunology in Blood Banking
GENETICS
Mendelian Laws:
•Law of Independent Segregation
• Gene exist in pairs and there must be only one gene to exist, to prevent gene
number in doubling in each succeeding generation
• Alleles of genes have no permanent effect on each other when present in the
same organism, but segregate unchanged by passing into different gametes
LAW OF INDEPENDENT ASSORTMENT
• Genes for different traits are inherited separately from each other; allows possible
combinations of genes to the offspring
• Members of one gene pair separate from one another independently of the member of
other gene pairs
1. Incomplete dominance
Expression of a phenotype that is intermediate to those of the parents
2. Codominant alleles
Full phenotypic expression of both members of a gene pair in the
heterozygous condition
3. Genes have more than two alleles
INCOMPLETE DOMINANCE
R2R2
R1R1 (WHITE)
(RED)
R1R2
(PINK)
CODOMINANT ALLELES
GENES HAVE MORE THAN TWO ALLELES
CELL DIVISION
2 types:
• MITOSIS – Division of somatic cells
• MEIOSIS - division that occurs only on gametes (sex cells)
IMMUNOLOGY IN BLOOD BANKING
IMMUNE SYSTEM:
Globulin- type of globular soluble protein found in the gamma globulin portion of serum
or plasma
POLYCLONAL AB MONOCLONAL AB
Antibodies produced in response to a Isolated individual B cells from a
single antigen with more than one polyclonal population and propagating
epitope them in cell culture with hybridoma
(single epitope)
Vary in antibody concentration from Contains Ab from a single type of B cell
person to person and animal to animal
Ab’s found in the serum of individuals who who have never Found in the serum of an individual who has been exposed
been previously exposed to RBC antigens to certain antigens (blood transfusion, pregnancy)
Probably produced in response to substances in the IgG antibodies - reacts best at 37degree Celsius and require
environment that resembles RBC antigens the use of AHG (Coombs sera) for detection
• IgM cold agglutinins • Rh, Kell, Duffy, Kidd and Ss blood group system
react best at RT or lower, activates complement,
may be hemolytic when active at 37 degree C
All individuals except newborn babies have
naturally acquired T cell independent, IgM abs in
their plasma that is directed against any ABO and H
antigens that is lacking to them
Produced after exposure to genetically different or non-self Produced in response to self antigens
RBC Ag’s after transfusion (foreign antigens)
Transfused components can elicit an immune response Patients with autoimmune disease.
Comes from alloantigens (present only in some Can cause reaction to the recipient if they have a
individuals) specificity that is common to the transfused blood. Some
One major problem in BB is when alloantibodies are no do not have detectable specificity are referred to as pan-
longer detectable in the patients serum or plasma, when polyagglutinins
transfused with immunizing Ag again; will make much
stronger immune response
React at different temperatures: cold or warm React at different temperatures: cold or warm
Not present in the recipient Can be removed by special adsorption and elution technique
Detected through antibody screening and identification Detected through antibody screening and identification
Positive in DAT and autocontrol
ZETA POTENTIAL
The net negative charge surrounding RBCs (and most other human cells) in a cationic media is
part of the force that repels RBCs from each other and is due to sialic acid molecules on the
surface of RBCs
Most acids have a negative charge, and the large concentration of these molecules on RBCs
creates a “zone” of negative charge around the RBC
This zone is protective and keeps RBCs from adhering to each other in the peripheral blood. A
potential is created because of the ionic cloud of cations (positively charged ions) that are
attracted to the zone of negative charges on the RBC membrane
Reducing the zeta potential allows the more positively charged antibodies to get closer to the
negatively charged RBCs and therefore increases RBC agglutination by IgG molecules
POTENTIATORS/ENHCANCEMENT MEDIA
Reagent Action Procedure Type of Ab ID
AHG Crosslinks sensitized 1. DAT 1.Polyspecific: anti-
cells, resulting in visible 2. IAT IgG+ anti-complement
(antihuman- agglutination (C3d)
globulin) 2. IgG monospecific:
anti-IgG only
Uses Human for reagent preparation (AHG) Do not use a human source
POLYCLONAL ANTIBODY PRODUCTION
Georges Kohler and Cesar Milstein were awarded the Nobel Prize
in 1984 for their work in monoclonal antibody production by
Hybridoma Technology
Monoclonal Antibody – Very specific derived from a single
antibody-producing cell that has been cloned or duplicated
Hybridoma – A cell line resulting from the fusion of myeloma cell
and a plasma cell. These can be maintained in tissue culture
indefinitely and can produce a very specific type of antibody known
as monoclonal antibody
•
• Hybridoma is produced as follows:
• 1. Mouse is immunized with a certain antigen and after a time, spleen cells are harvested.
• 2. Spleen cells are combined with myeloma cells in the presence of polyethylene glycol
(PEG), a surfactant. The PEG brings about fusion of plasma cells with myeloma cells, producing
a hybridoma
• 3. After fusion, cells are placed in culture using HAT Medium (medium containing
hypoxanthine, aminopterin, thymidine). The medium ALLOWS Hybridoma cells to grow
selectively in tissue culture. MYELOMA CELLS (cancerous plasma cells) CANNOT grow in this
medium because of the myeloma cell line is deficient in the required enzymes hypoxanthine
guanine phosphoribosyl transferase (HGPRT) and thymidine kinase. Also, the growth of
myeloma cells is blocked by the presence of aminopterin
• 4. Myeloma cells and even normal B cells die out, leaving behind the fused hybridoma cells
• 5. Remaining hybridoma cells are diluted out and placed in microtiter wells where they are
allowed to grow. Each well containing one clone is then screened for the presence of
desired antibody by removing the supernatant
• 6. Once identified, a hybridoma is capable of being maintained in cell culture indefinitely
and it produces a ready supply of monoclonal antibody that reacts with a single epitope
Mouse plasma cell + myeloma cell = hybridoma cell
FACTORS ANTIGEN-ANTIBODY REACTIONS:
Intermolecular binding forces
Ionic bonds, Hydrogen bonds, Hydrophobic bonds, Van der Waals forces
Antibody properties
AFFINITY: initial force of interaction that exists between a single fab site on an
antibody molecule and single epitope or determinant site on the corresponding
antigen
AVIDITY: sum/strength of all attractive forces between an antigen and an antibody
Host factors
nutritional status, hormones, genetic inheritance, age, race, sex, physical activity,
and environmental exposure, occurrence of disease or injury
Tolerance
DETECTION OF RBC-ANTIGEN ANTIBODY REACTIONS
AGGLUTINATION
process by which particulate antigens such as cells aggregate to form large complexes
when a specific antibody is present
HEMAGGLUTINATION Antigen is found on red cells
HAS TWO PHASES:
Sensitization antigen binding to the antibody (epitopes on the RBC membrane
binds with the Fab region of the antibodies), no visible agglutination
Lattice-formation multiple antigen-antibody bridges RBC antigens and
antibodies is formed; with visible agglutination
HEMOLYSIS
Disruption of the red blood cell membrane and the subsequent release of hemoglobin into the suspending
medium or plasma
PHASES OF AGGLUTINATION
AGGLUTINATION GRADING
NEGATIVE AGGLUTINATION VS HEMOLYSIS
END